Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

Trial Profile

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Risperidone; Serotonin uptake inhibitors
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2017 Planned End Date changed from 1 Dec 2006 to 1 Mar 2006.
    • 27 Aug 2007 Status changed from in progress to withdrawn. The study was withdrawn prior to recruitment due to failed recruitment efforts.
    • 10 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top